Skip to content

Public FDA record

Z-2081-2014: AGFA Digital Radiography X-Ray system DX-D 100 Agfa's DX-D 100 is indicated for use in providing diagn

Recall record Z-2081-2014 for AGFA Corp.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-2081-2014
Company in FDA record
AGFA Corp.
FDA classification date
Jul 21, 2014
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

When liquid comes in contact with the DX-D 100 touch screen, the device may incorrectly recognize this as user input altering device settings.

Source facts

Action
Agfa Healthcare sent an "URGENT FIELD SAFETY NOTICE" dated June 6, 2014, to the US and Canadian customers. The letter described the safety alert and mitigation. Acknowledgment, via FAX-Back or email, that the information was received and understood was requested from the customers. Although medical staff are required to disinfect hands on a frequent basis, users must ensure that their hands are dry before using the touch screen of the DX-0100 because liquid residue may activate the action buttons on the touch screen. Customers were instructed: "Do not operate touch screen monitor with wet hands! "Do not let liquids come in contact with the touch screen while the DXD 100 is powered on! "Always double check your parameter settings prior to exposing the patient. We would like to remind you of this specific warning statement in the DX-0100 User Manual. Please complete the feedback form as soon as possible and return it to us by June 16, 2014. Should the above information not apply to your facility or should the device have been transferred to another organization, please be so kind as to indicate this on the attached feedback form and pass this Urgent Field Safety Notice to the organization where the device has been transferred. We thank you for your careful attention to this issue and your continued support. If you have any questions about this matter, please contact your local Agfa Healthcare organization: 1-877-777-2432, prompt 1 and reference PR1406020002
Initiated
2014-06-06
Root cause
Use error
Terminated
2016-06-27
Distribution
USA (nationwide) including the states of AL, CA, FL, GA, IL, IN, IA, KY, LA, MA, MI, MN, MS, MO, NE, NJ, NY, NC, OH, SC, TN, TX, VA, WV, WI, WY and Internationally to Canada.
Recall number
Z-2081-2014
Recall status
Terminated
CDRH record ID
128232
FDA classified
2014-07-21
Recall event number
68567

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗